Henry Schein, Inc. (NASDAQ:HSIC) Shares Sold by APG Asset Management N.V.

APG Asset Management N.V. lessened its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 51.2% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 122,541 shares of the company's stock after selling 128,808 shares during the period. APG Asset Management N.V. owned about 0.10% of Henry Schein worth $7,329,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of HSIC. Summit Securities Group LLC bought a new position in Henry Schein in the 2nd quarter worth about $31,000. Beach Investment Counsel Inc. PA purchased a new position in Henry Schein during the 2nd quarter worth $37,000. Blue Trust Inc. raised its position in Henry Schein by 104.2% during the 2nd quarter. Blue Trust Inc. now owns 931 shares of the company's stock valued at $60,000 after purchasing an additional 475 shares in the last quarter. Mather Group LLC. purchased a new stake in shares of Henry Schein in the 1st quarter worth $97,000. Finally, Palisade Asset Management LLC bought a new position in shares of Henry Schein during the 1st quarter worth $113,000. Institutional investors own 96.62% of the company's stock.

Insiders Place Their Bets

In other news, SVP Lorelei Mcglynn sold 21,035 shares of Henry Schein stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $69.30, for a total value of $1,457,725.50. Following the sale, the senior vice president now directly owns 71,833 shares of the company's stock, valued at $4,978,026.90. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.14% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on HSIC shares. Evercore ISI lowered their price objective on shares of Henry Schein from $72.00 to $70.00 and set an "in-line" rating for the company in a research note on Wednesday, August 7th. Piper Sandler reaffirmed an "overweight" rating and set a $86.00 target price on shares of Henry Schein in a research report on Friday, June 21st. Barrington Research reissued an "outperform" rating and issued a $82.00 price target on shares of Henry Schein in a research report on Friday, September 20th. Baird R W upgraded Henry Schein from a "hold" rating to a "strong-buy" rating in a research note on Monday, July 22nd. Finally, JPMorgan Chase & Co. decreased their price target on shares of Henry Schein from $88.00 to $80.00 and set an "overweight" rating for the company in a research report on Monday, August 12th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $77.10.

Henry Schein Stock Performance

HSIC traded down $0.32 during midday trading on Monday, hitting $72.90. 1,379,157 shares of the company were exchanged, compared to its average volume of 1,355,476. The firm has a market capitalization of $9.33 billion, a price-to-earnings ratio of 24.63, a price-to-earnings-growth ratio of 2.01 and a beta of 0.86. Henry Schein, Inc. has a 1-year low of $60.01 and a 1-year high of $82.63. The company's 50 day simple moving average is $70.14 and its 200 day simple moving average is $70.17. The company has a current ratio of 1.55, a quick ratio of 0.90 and a debt-to-equity ratio of 0.46.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its earnings results on Tuesday, August 6th. The company reported $1.23 earnings per share for the quarter, beating the consensus estimate of $1.22 by $0.01. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. The firm had revenue of $3.10 billion during the quarter, compared to analyst estimates of $3.27 billion. During the same period in the previous year, the firm earned $1.31 EPS. The business's quarterly revenue was up .0% on a year-over-year basis. As a group, sell-side analysts predict that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.